Xiubin L. Li

No 69 Yongding Road
Yongding, 100039, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications

A Blood-Triggered Adhesive Hydrogel Loaded with Reactive Oxygen Species-Responsive Liposomes for the Treatment of Acute Kidney Injury.

A Blood-Triggered Adhesive Hydrogel Loaded with Reactive Oxygen Species-Responsive Liposomes for the Treatment of Acute Kidney Injury.

Journal: ACS nano
Published: April 22, 2026

Kidney‑enriched lipid nanoparticles delivering ANXA2 alleviate renal ischemia-reperfusion injury via CHMP2A-mediated necroptosis inhibition.

Kidney‑enriched lipid nanoparticles delivering ANXA2 alleviate renal ischemia-reperfusion injury via CHMP2A-mediated necroptosis inhibition.

Journal: Journal of nanobiotechnology
Published: March 06, 2026

Macrophage AMPK activated by oxidative stress drives profibrotic crosstalk with tubular cells to accelerate renal fibrosis after ischemic and reperfusion injury.

Macrophage AMPK activated by oxidative stress drives profibrotic crosstalk with tubular cells to accelerate renal fibrosis after ischemic and reperfusion injury.

Journal: Redox biology
Published: November 16, 2025

KLHDC4 serves as a novel prognostic biomarker and drives tumor progression via PI3K/AKT signaling in clear cell renal cell carcinoma.

KLHDC4 serves as a novel prognostic biomarker and drives tumor progression via PI3K/AKT signaling in clear cell renal cell carcinoma.

Journal: Scientific reports
Published: October 30, 2025

Multi-omics analysis of kidney renal cell carcinoma in silico with preliminary in vivo validation.

Multi-omics analysis of kidney renal cell carcinoma in silico with preliminary in vivo validation.

Journal: Frontiers in immunology
Published: October 27, 2025

PABPC1-induced stabilization of PGK1 mRNA reduces apoptosis and sunitinib sensitivity in renal cell carcinoma by suppressing endoplasmic reticulum stress.

PABPC1-induced stabilization of PGK1 mRNA reduces apoptosis and sunitinib sensitivity in renal cell carcinoma by suppressing endoplasmic reticulum stress.

Journal: Cell death & disease
Published: September 29, 2025

PD-1 blockade plus tyrosine kinase inhibitor remodels the tumor microenvironment in advanced renal cell carcinoma.

PD-1 blockade plus tyrosine kinase inhibitor remodels the tumor microenvironment in advanced renal cell carcinoma.

Journal: Nature communications
Published: August 06, 2025

SV2B Promotes the Progression of TFE3-Rearranged Renal Cell Carcinoma by Interacting with HERC2 to Impede the Degradation of NF-κB Subunits.

SV2B Promotes the Progression of TFE3-Rearranged Renal Cell Carcinoma by Interacting with HERC2 to Impede the Degradation of NF-κB Subunits.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: May 25, 2025

Integrated bioinformatics analysis reveals novel PANoptosis biomarkers and therapeutic response in clear cell renal cell carcinoma.

Integrated bioinformatics analysis reveals novel PANoptosis biomarkers and therapeutic response in clear cell renal cell carcinoma.

Journal: Clinical and experimental medicine
Published: May 07, 2025

RhoJ promotes the progression of clear cell renal cell carcinoma via the TNF-α/NF-κB axis.

RhoJ promotes the progression of clear cell renal cell carcinoma via the TNF-α/NF-κB axis.

Journal: Translational andrology and urology
Published: February 21, 2025

GAMT facilitates tumor progression via inhibiting p53 in clear cell renal cell carcinoma.

GAMT facilitates tumor progression via inhibiting p53 in clear cell renal cell carcinoma.

Journal: Biology direct
Published: February 05, 2025

LGI3 promotes the progression of TFE3-rearranged renal cell carcinoma through GEMIN6/AURKB axis.

LGI3 promotes the progression of TFE3-rearranged renal cell carcinoma through GEMIN6/AURKB axis.

Journal: Oncogene
Published: January 22, 2025
Showing 1-12 of 32

Last Updated: 09/26/2026